1. Kim, J. W.; Min, S. W.; Lee, J.; Shin, H. G.; Choi, H. L.; Yang, H. R.; Lee, J. H.; Cho, Y. B.; Shim, H.; Lee, S. Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2. Biomedicines 2022, 10 (12). DOI: 10.3390/biomedicines10123274 2. Lee, J. H.; Kim, J. W.; Yang, H. R.; Song, S. W.; Lee, S. J.; Jeon, Y.; Ju, A.; Lee, N.; Kim, M. G.; Kim, M.; Hwang, K.; Yoon, J. H.; Shim, H.; Lee, S. A Fully-Human Antibody Specifically Targeting a Membrane-Bound Fragment of CADM1 Potentiates the T Cell-Mediated Death of Human Small-Cell Lung Cancer Cells. Int. J. Mol. Sci. 2022, 23 (13). DOI: 10.3390/ijms23136895 3. Shin, H. G.; Yang, H. R.; Yoon, A.; Lee, S. Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy. Int. J. Mol. Sci. 2022, 23 (10). DOI: https://doi.org/10.3390/ijms23105686 4. Cho, Y. B.; Kim, J. W.; Heo, K.; Kim, H. J.; Yun, S.; Lee, H. S.; Shin, H. G.; Shim, H.; Yu, H.; Kim, Y. H.; Lee, S. An internalizing antibody targeting of cell surface GRP94 effectively suppresses tumor angiogenesis of colorectal cancer. Biomedicine & pharmacotherapy 2022, 150, 113051. DOI: 10.1016/j.biopha.2022.113051 5. Kim, J. W.; Lee, S. Current status and perspectives on CAR-T therapy. Front. Biosci. (Landmark Ed.) 2021, 26 (12), 1393-1395. DOI: 10.52586/5033
|